Association of genetic variants in CYP2C19 and adverse clinical outcomes after treatment with clopidogrel: An updated meta-analysis

被引：17
|
作者：
Liu, Yan Ping [3 ]
Hao, Pan Pan [1 ,2 ]
Zhang, Ming Xiang [1 ,2 ]
Zhang, Cheng [1 ,2 ]
Gao, Fei [1 ,2 ]
Zhang, Yun [1 ,2 ]
Chen, Yu Guo [1 ,2 ]
机构：
[1] Shandong Univ, Qilu Hosp, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250012, Peoples R China
[2] Shandong Univ, Qilu Hosp, Chinese Minist Publ Hlth, Jinan 250012, Peoples R China
[3] Shandong Univ, Sch Med, Inst Expt Nucl Med, Jinan 250012, Peoples R China
来源：
THROMBOSIS RESEARCH | 2011年 / 128卷 / 06期
关键词：
PERCUTANEOUS CORONARY INTERVENTION; OF-FUNCTION POLYMORPHISM; STENT THROMBOSIS; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; TREATED PATIENTS; RISK; GENOTYPE; CYP2C19-ASTERISK-2; ACTIVATION;
D O I：
10.1016/j.thromres.2011.07.003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：593 / 594
页数：2
相关论文
共 50 条
  • [31] The clinical impact of CYP2C19 *2 and *3 polymorphism on Clopidogrel and cost analysis
    Al Meman A
    Khalaf H
    Rasool Seemab
    BMC Genomics, 15 (Suppl 2)
  • [32] Influence of Genetic Polymorphisms on Clopidogrel Response and Clinical Outcomes in Patients with Acute Ischemic Stroke CYP2C19 Genotype on Clopidogrel Response
    Han, Yan
    Lv, Hui-Hui
    Liu, Xu
    Dong, Qiang
    Yang, Xiao-Li
    Li, Shi-Xu
    Wu, Shuai
    Jiang, Jian-Ming
    Luo, Zheng
    Zhu, De-Sheng
    Zhang, Yi
    Zheng, Yi
    Guan, Yang-Tai
    Xu, Jian-Feng
    CNS NEUROSCIENCE & THERAPEUTICS, 2015, 21 (09) : 692 - 697
  • [33] Positive Clinical Response to Clopidogrel is Independent of Paraoxonase 1 Q192R and CYP2C19 Genetic Variants
    Martinez-Quintana, Efren
    Medina-Gil, Jose M.
    Rodriguez-Gonzalez, Fayna
    Garay-Sanchez, Paloma
    Liminana, Jose M.
    Saavedra, Pedro
    Tugores, Antonio
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (08): : 843 - 849
  • [34] Prevalence of CYP2C19*2 and CYP2C19*3 Allelic Variants and Clopidogrel Use in Patients with Cardiovascular Disease in Trinidad & Tobago
    Daniele Jones
    Shana Persad-Ramdeensingh
    Sheherazade Crystal Abrahim
    Naveen Seecheran
    Rajini Rani Haraksingh
    Cardiology and Therapy, 2024, 13 : 191 - 203
  • [35] CYP2C19 Genotype, Clopidogrel Metabolism, Platelet Function, and Cardiovascular Events A Systematic Review and Meta-analysis
    Holmes, Michael V.
    Perel, Pablo
    Shah, Tina
    Hingorani, Aroon D.
    Casas, Juan P.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (24): : 2704 - 2714
  • [36] Prevalence of CYP2C19*2 and CYP2C19*3 Allelic Variants and Clopidogrel Use in Patients with Cardiovascular Disease in Trinidad & Tobago
    Jones, Daniele
    Persad-Ramdeensingh, Shana
    Abrahim, Sheherazade Crystal
    Seecheran, Naveen
    Haraksingh, Rajini Rani
    CARDIOLOGY AND THERAPY, 2024, 13 (01) : 191 - 203
  • [37] Implementation and management outcomes of pharmacogenetic CYP2C19 testing for clopidogrel therapy in clinical practice
    Stefan Russmann
    Ali Rahmany
    David Niedrig
    Karl-Dietrich Hatz
    Katja Ludin
    Andrea M. Burden
    Lars Englberger
    Roland Backhaus
    Andreas Serra
    Markus Béchir
    European Journal of Clinical Pharmacology, 2021, 77 : 709 - 716
  • [38] Impact of the CYP2C19 Gene Polymorphism on Clopidogrel Personalized Drug Regimen and the Clinical Outcomes
    Chen, Keguang
    Zhang, Rui
    Liu, Huanjun
    Guo, Xi
    Li, Pingli
    Liu, Xuehong
    CLINICAL LABORATORY, 2016, 62 (09) : 1773 - 1780
  • [39] Implementation and management outcomes of pharmacogenetic CYP2C19 testing for clopidogrel therapy in clinical practice
    Russmann, Stefan
    Rahmany, Ali
    Niedrig, David
    Hatz, Karl-Dietrich
    Ludin, Katja
    Burden, Andrea M.
    Englberger, Lars
    Backhaus, Roland
    Serra, Andreas
    Bechir, Markus
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (05) : 709 - 716
  • [40] Effect of CYP2C19 genetic polymorphism on the pharmacodynamics and clinical outcomes for patients treated with ticagrelor: a systematic review with qualitative and quantitative meta-analysis
    Qiufen Xie
    Qian Xiang
    Zhiyan Liu
    Guangyan Mu
    Shuang Zhou
    Zhuo Zhang
    Lingyue Ma
    Yanjun Gong
    Jie Jiang
    Yimin Cui
    BMC Cardiovascular Disorders, 22
12345